Vaginal Slings Market Analysis | United States | 2017-2023 | MedCore

Vaginal Slings Market Analysis | United States | 2017-2023 | MedCore

0

Vaginal slings or urinary incontinence slings are medical devices placed under the urethra through a small incision to treat incontinence symptoms. Stress urinary incontinence (SUI) can be classified in three forms: intrinsic sphincter deficiency (ISD), urethral hypermobility or male loss of internal and external sphincter functionality. Slings are commonly used in women who have urethral hypermobility. A sling will stop the hypermobility, but the patient may still have stress urinary incontinence due to an intrinsic sphincter deficiency (ISD). ISD occurs when the urethral sphincter is unable to generate enough resting pressure to prevent urine from seeping out. Urethral hypermobility, also known as Type II SUI, is due to weakened anatomic urethral support, often caused by childbearing. Male loss of sphincter functionality is relatively rare. Vaginal slings directly compete with bulking agents; however, slings are considered the leading technology for treating SUI.

  • Year: 2017
  • Scope: 2013-2023
  • Region: United States
  • Published Date: 7/1/2017
  • Pages: 527
  • Type: MedCore

In the next few years, the biologic market will continue to grow at a faster pace than the synthetic market, however this trend will reverse itself by 2020. Most vaginal sling implantation procedures are performed on an in-patient basis; however, recently the trend has been moving towards out-patient surgery. This trend is due to the gaining popularity of single-incision slings and other easier to install versions of traditional vaginal sling devices that reduce the degree of invasiveness of the implantation procedure, often allowing for the surgery to be conducted in an out-patient setting.

Vaginal slings always require a surgical procedure for installation; however, the degree of invasiveness of the procedure varies depending on the type of sling. The procedure involves placing a sling around the urethra to lift it to a position where sufficient urethral compression will achieve urine control. The sling provides structural support similar to a hammock under the urethra. Slings can consist of synthetic materials, biologic materials or autologous tissue harvested from the patient.

Segments Covered in This Market

  • Synthetic Market
  • Biologic Market

Report Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • 10 Year Scope (3 Year Historical + 7 Year Forecast Period)
  • Market Drivers & Limiters for Each Segment
  • Competitive Analysis with Market Shares
  • Product Portfolios
  • Related Press Releases from Top Competitors

Companies Analyzed

Boston Scientific offers a wide variety of synthetic slings including Advantage Fit™ Transvaginal, Advantage™ Transvaginal, Lynx™ Suprapubic, and Obtryx™ II Transobturator systems. All these products utilize Boston Scientific’s Advantage™ Mesh, which is designed to reduce the risk of deformation and vaginal wall irritation. Ethicon Inc., a subsidiary of Johnson & Johnson, offers the Gynecare® TVT™ family of synthetic tensionfree slings. Coloplast offered a large variety of synthetic products, including the Aris® and Supris®. Other companies analyzed include C.R. Bard.

About Our In-Depth MedCore Research

Our analysts meticulously research for up to 3 to 4 months to put together one suite of reports (MedSuite), which is a comprehensive analysis on a group of healthcare markets. A MedCore is one portion of that analysis that focuses on one market segment, and provides further detailed segmentation to get a much more granular set of market data.

This MedCore is also found in the full report suite titled U.S. Market Report Suite for Soft Tissue Reinforcement and Regeneration – MedSuite

Learn More about these product types



The "US Market Report Suite for Soft Tissue Reinforcement and Regeneration 2017 - MedSuite" includes analysis on the following companies currently active in this market:
LifeCell
Organogenesis
C.R. Bard
Ethicon
Covidien
Arthrex
ASTORA
Wright Medical
Integra LifeSciences
Smith & Nephew
MiMedx
Boston Scientific
Systagenix
BioHorizons
Atrium Medical
Coloplast
Stryker
Cook Medical
Johnson & Johnson
Osiris
Soluble Systems
Synovis/Baxter
KCI
RTI Biologics
Geistlich
TEI
Zimmer Biomet
ACell
Aesculap/B. Braun
Gore Medical
Medtronic
Dentsply
Others include: Medline, MTF, WL Gore, Tutogen, Novus Scientific, Ariste Medical
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.




Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Not Exactly What You Need?
close-link
close-link
close-link

Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers

close-link
close-link
close-link